Concepedia

Sophie Harris

SH

Statistics

Publications

9

Citations

1.5K

H-Index

9

Active since

2018

Affiliations

University of Oxford(Current)

King's College London

University of Bristol

University of Edinburgh

Gloucestershire Health and Care NHS Foundation Trust

Sophie Harris is an author at University of Oxford specializing in pharmacotherapy, 28-day mortality, and primary outcome analysis.

Publications per year

2018–2023

9

Publications

9

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2023 · 132 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Clinical and multi-omics cross-phenotyping of patients with autoimmune and autoinflammatory diseases: the observational TRANSIMMUNOM protocol

Roberta Lorenzon, Encarnita Mariotti‐Ferrandiz, Caroline Aheng et al. · BMJ Open · 2018 · 38 citations · Full text

Life Sciences, Immunology, Systems Biology +17

1–5 of 9